ERCC1 and breast carcinoma: This case-control study revealed the susceptibility of carriers of ERCC1 variant rs11615 to increased risk of breast cancer, consistent with previous observations that ERCC1 rs11615 was associated with reduced mRNA [28] and protein [29] expression levels, and consequently impaired DNA repair capacity [28].